2021 Emerging Blood Typing, Grouping and NAT Screening Technologies, and Strategic Profiles of Leading Suppliers
This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for blood banking.
The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Contains 114 pages
The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Contains 114 pages
Current and Emerging Technologies
Molecular Diagnostics
a. Overview
b. NAT
Monoclonal and Polyclonal Antibodies
Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
Microtitration Plates
IT and Automation
Lasers
Robotics
Synthetic Red Cell Substitutes
Genetically Engineered Blood Components
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t-PA
Table of Contents (Continued)
Blood Preservation
Autologous Blood Transfusion/Freezing
COMPETITIVE PROFILES
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Grifols
Hologic
Immucor
LabCorp
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens Healthineers
Tecan
Thermo Fisher
Molecular Diagnostics
a. Overview
b. NAT
Monoclonal and Polyclonal Antibodies
Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
Microtitration Plates
IT and Automation
Lasers
Robotics
Synthetic Red Cell Substitutes
Genetically Engineered Blood Components
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t-PA
Table of Contents (Continued)
Blood Preservation
Autologous Blood Transfusion/Freezing
COMPETITIVE PROFILES
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Grifols
Hologic
Immucor
LabCorp
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens Healthineers
Tecan
Thermo Fisher
More Publications
2016-2020 Emerging Blood Typing, Grouping and NAT Screening Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
US$ 3,080.00
March 2016
225 pages
2016-2020 Emerging Opportunities in the Microbiology Testing Market: Strategic Assessments of Leading Suppliers
US$ 1,480.00
March 2016
90 pages
2016-2020 Emerging Opportunities in the Hemostasis Testing Market: Strategic Assessments of Leading Suppliers
US$ 2,800.00
March 2016
165 pages
2016-2020 World Blood Typing, Grouping and Infectious Disease Screening Market: Insightful Profiles of Major Suppliers and Emerging Market Entrants
US$ 2,200.00
March 2016
50 pages
2016-2020 Emerging Hematology and Flow Cytometry Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
US$ 3,080.00
March 2016
106 pages
